Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions.

IF 1.8 4区 医学 Q3 GENETICS & HEREDITY
Familial Cancer Pub Date : 2024-08-01 Epub Date: 2024-05-11 DOI:10.1007/s10689-024-00394-z
Bas Boekestijn, Shirin Feshtali, Hans Vasen, Monique E van Leerdam, Bert A Bonsing, J Sven D Mieog, Martin N Wasser
{"title":"Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions.","authors":"Bas Boekestijn, Shirin Feshtali, Hans Vasen, Monique E van Leerdam, Bert A Bonsing, J Sven D Mieog, Martin N Wasser","doi":"10.1007/s10689-024-00394-z","DOIUrl":null,"url":null,"abstract":"<p><p>Pancreatic cancer has a dismal prognosis in the general population. However, early detection and treatment of disease in high-risk individuals can improve survival, as patients with localized disease and especially patients with lesions smaller than 10 mm show greatly improved 5-year survival rates. To achieve early detection through MRI surveillance programs, optimization of imaging is required. Advances in MRI technologies in both hardware and software over the years have enabled reliable detection of pancreatic cancer at a small size and early stage. Standardization of dedicated imaging protocols for the pancreas are still lacking. In this review we discuss state of the art scan techniques, sequences, reduction of artifacts and imaging strategies that enable early detection of lesions. Furthermore, we present the imaging features of small pancreatic cancers from a large cohort of high-risk individuals. Refinement of MRI techniques, increased scan quality and the use of artificial intelligence may further improve early detection and the prognosis of pancreatic cancer in a screening setting.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"295-308"},"PeriodicalIF":1.8000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254973/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Familial Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10689-024-00394-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/11 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Pancreatic cancer has a dismal prognosis in the general population. However, early detection and treatment of disease in high-risk individuals can improve survival, as patients with localized disease and especially patients with lesions smaller than 10 mm show greatly improved 5-year survival rates. To achieve early detection through MRI surveillance programs, optimization of imaging is required. Advances in MRI technologies in both hardware and software over the years have enabled reliable detection of pancreatic cancer at a small size and early stage. Standardization of dedicated imaging protocols for the pancreas are still lacking. In this review we discuss state of the art scan techniques, sequences, reduction of artifacts and imaging strategies that enable early detection of lesions. Furthermore, we present the imaging features of small pancreatic cancers from a large cohort of high-risk individuals. Refinement of MRI techniques, increased scan quality and the use of artificial intelligence may further improve early detection and the prognosis of pancreatic cancer in a screening setting.

Abstract Image

利用磁共振成像筛查高危人群中的胰腺癌:优化扫描技术以检测微小病灶。
胰腺癌在普通人群中的预后很差。然而,对高危人群进行早期发现和治疗可以提高生存率,因为局部疾病患者,尤其是病灶小于 10 毫米的患者的 5 年生存率大大提高。要通过磁共振成像监测计划实现早期发现,就必须优化成像技术。多年来,核磁共振成像技术在硬件和软件两方面都取得了进步,能够可靠地检测出小病灶和早期阶段的胰腺癌。但胰腺专用成像方案仍缺乏标准化。在这篇综述中,我们将讨论最先进的扫描技术、序列、减少伪影以及能够早期发现病变的成像策略。此外,我们还介绍了一大批高危人群中小胰腺癌的成像特征。核磁共振成像技术的改进、扫描质量的提高以及人工智能的使用可进一步改善胰腺癌筛查的早期发现和预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Familial Cancer
Familial Cancer 医学-遗传学
CiteScore
4.10
自引率
4.50%
发文量
36
审稿时长
6-12 weeks
期刊介绍: In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers. Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician. The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信